Debunking Sex and Disentangling Gender From Oncology

Abstract

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. SUPPORT A.B.A.'s time is supported by an Agency for Healthcare Research and Quality T32HS000011. J.O.-M.'s time is partially supported by the National Institutes of Health (R21MD015878, R21CA237670, R01DA052016).

Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations

“…Estimation of risk levels and factors, and cancer outcomes among transgender and gender-diverse individuals require availability of quality data about sexual orientation, gender identity, gender affirmation, anatomy, and hormone status of our patients as part of cancer registry and other data collections. 10 , 11 Whereas the collection of sex-related information is common in cisgender patients, for example the menopausal or reproductive status of cisgender women, these elements are commonly overlooked and often assumed in transgender and gender-diverse people, mostly in individuals who are non-binary–a term used to describe people whose gender identity extends beyond the categories of male and female-that represent a significant and growing proportion of gender-diverse population. Assumptions and prejudices underlie misinformed data and hamper the estimation of the real extent of disparities across the cancer care continuum.…”